Skip to main content
MedPathMedPath Home
Clinical Trials/JPRN-UMIN000009909
JPRN-UMIN000009909
Recruiting
Phase 4

Prospective, Single center, Registry to Evaluate the Long-term Clinical Safety and Efficacy of the Resolute Integrity drug eluting stent in an all-comers population. - Resolute Integrity-KUKI Registry

Department of Cardiovascular Internal Medicine, Kuki General Hospital0 sites1,000 target enrollmentJanuary 31, 2013
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsCoronary artery disease (CAD)

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Coronary artery disease (CAD)
Sponsor
Department of Cardiovascular Internal Medicine, Kuki General Hospital
Enrollment
1000
Status
Recruiting
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
January 31, 2013
End Date
TBD
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Department of Cardiovascular Internal Medicine, Kuki General Hospital

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • •1\.Patients with cardiogenic shock 2\.Patients who are pregnant or possibly pregnant 3\.Patients who cannot comply with the antiplatelet therapy specified for this clinical study 4\.Patients scheduled to undergo elective surgery within 6 months post\-index PCI 5\.Patients with a history of allergic reaction or hypersensitivity to zotarolimus, sirolimus, tacrolimus, everolimus, or other analogues or derivatives 6\.Patients with an allergic reaction to antiplatelet or anticoagulant drugs, such as heparin, aspirin, ticlopidine, or clopidogrel, or contrast agents, or those who cannot tolerate these substances and to whom appropriate treatments cannot be given 7\. Patient who underwent stent treatment with BMS in other lesions within 6 months prior to the conduct of index PCI of the target vessel

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Not Applicable
Evaluation of the Impact of Fractional flow reserve and Optical Coherence Tomography on the Outcomes of Percutaneous coronary intervention in Diabetic Patients
CTRI/2021/09/036375Ananthapuri Hospitals and Research Institute
Not yet recruiting
Not Applicable
Data collection registry to assess the performance of Confirm RxTM Insertable Cardiac Monitor (ICM) and system over a 12 month periodHealth Condition 1: I48- Atrial fibrillation and flutter
CTRI/2019/06/019717St Jude Medical Abbott
Recruiting
Not Applicable
A follow up study to evaluate the safety and effectiveness of tissue valve (aortic) among Indian patientsHealth Condition 1: I358- Other nonrheumatic aortic valve disorders
CTRI/2022/08/044557SRM Institutes for Medical Science SIMS
Active, not recruiting
Not Applicable
An observational registry study on the use of ENCRUSO RAL- Everolimus eluting stent in indian populatio
CTRI/2022/03/040921ano Therapeutics Private Limited
Recruiting
Phase 4
A Observational Study to Evaluate Sirolimus Eluting Coronary Stent for the Treatment of the narrowing of the coronary artery, resulting in a poor blood flow to your heart muscle.
CTRI/2012/04/002612Multimedics400